ALBANY, Ga. (WALB) - Merck is asking a Georgia court to dismiss a lawsuit tied to the former Albany pharmaceutical plant. The original complaint, filed Oct. 7, 2025, by Beasley Allen Law Firm on ...

Nature of the Case and Issue(s) Presented: Merck owned U.S. Patent No. 6,670,340 (“the ‘’340 patent”), which issued on Dec. 30, 2003, and claimed a class of 6-mercaptocyclodextrin derivatives, ...

Beginning in November 2024, Merck Sharp & Dohme, LLC (“Merck”) requested post-grant review (“PGR”) of 14 patents owned by Halozyme, Inc. (“Halozyme”), with claims directed to modified PH20 ...

(RTTNews) - Halozyme Therapeutics (HALO) filed a patent infringement lawsuit against Merck Sharp & Dohme Corp. in U.S. District Court in New Jersey. Halozyme believes the subcutaneous formulation of ...

Jones Day partners Jason T. Burnette, Joseph 'Joe' E. Finley and Stephanie E. Parker have entered appearances for Merck & Co. and Merck Sharp & Dohme in a pending wrongful death lawsuit over alleged ...

Merck Sharp & Dohme LLC has identified receptor-interacting serine/threonine-protein kinase 1 (RIPK1; RIP-1) inhibitors reported to be useful for the treatment of amyotrophic lateral sclerosis, ...

Merck Sharp & Dohme LLC has prepared and tested triggering receptor expressed on myeloid cells 2 (TREM2) agonists reported to be useful for the treatment of Alzheimer’s disease and neurodegeneration.

Article ‘Count’ and ‘Share’ for Merck Sharp and Dohme B.V. (MSD BV Haarlem) based on listed parameters only. The articles listed below published by authors from Merck Sharp and Dohme B.V. (MSD BV ...

Article ‘Count’ and ‘Share’ for Merck Sharp and Dohme B.V. (MSD BV Haarlem) based on listed parameters only. According to the parameters selected above, there are no articles from Merck Sharp and ...